Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

FDA Approves the Only Full-Body MR Conditional Deep Brain Stimulation Systems

December 9, 2015 By Medtronic

Medtronic plc today announced that systems within its Activa portfolio of Deep Brain Stimulation (DBS) neurostimulators have received FDA approval for full-body Magnetic Resonance Imaging (MRI)* under specific conditions of use. Medtronic’s MR Conditional DBS systems are the only approved for full-body MRI scans. This approval expands access to MRIs, making it safe for patients receiving Medtronic DBS Therapy to also receive this important diagnostic standard of care. Additionally, this approval applies to individuals receiving new Medtronic DBS systems and to an estimated 43,000 people in the U.S. already receiving Medtronic DBS Therapy as long as updated MRI guidelines are followed.*

In 2013, 33.8 million MRI scans were performed in the U.S.1 and approximately 7 out of 10 DBS-eligible patients with movement disorders may need an MRI within 10 years of receiving their device.2 MRI scans allow physicians to detect and/or monitor a wide range of health conditions, such as stroke, dementia, movement disorders, brain tumors, seizures, diseases of the spine, cancer, musculoskeletal issues and cardiac issues. MRIs use magnetic fields and radio waves to create detailed pictures of organs and tissues, but unlike conventional X-ray and computed tomography (CT), they do not expose patients to ionizing radiation.

“Access to full-body MRI scans has been a critical unmet need with DBS therapy, as many patients require MRI imaging but could not always safely obtain it,” said Michael S. Okun, national medical director at the National Parkinson Foundation. “There will be important guidelines for centers to follow in order to apply MRI imaging in patients, however, the availability of this type of imaging is an important step that will facilitate a more optimal care experience.”

Since FDA approval of MRI instructions for use in 2002, patients with Medtronic DBS could receive head scans at a low radiofrequency (RF) power limit and the DBS system had to be turned off before the MRI scan.  Now with full-body scanning capability, increased MRI RF power limits allow for improved image quality, faster scan times, or larger scan coverage for better diagnostic capabilities.  Additionally, when programmed to appropriate stimulation settings and certain other conditions have been met, Medtronic DBS systems allow patients to continue receiving therapy during scans.

“The use of MRI as a diagnostic tool has grown significantly, and Medtronic is proud to offer the only DBS systems that allow patients access to full-body MRIs,” said Lothar Krinke, Ph.D., vice president and general manager of the Brain Modulation business, which is part of the Restorative Therapies Group at Medtronic. “Continuous innovation sets Medtronic apart, and we are allowing greater access to MRIs for those receiving DBS therapy as well as other implanted Medtronic systems such as pacemakers, ICDs and spinal cord stimulators.”

To ensure our devices are safe, Medtronic performed rigorous testing, including developing proprietary test and measurement systems, in conjunction with advanced electromagnetic modeling tools. Activa DBS systems were tested and evaluated across 10 million simulated patient scans spanning over 38,000 unique implant conditions to demonstrate patient safety. In all, Medtronic has 14 years of MRI research and testing experience.

*MR Conditional. Before conducting an MRI examination on a patient with any implanted Medtronic DBS device, please refer to the MRI guidelines for Medtronic deep brain stimulation systems located at www.medtronic.com/mri.

References
1IMV. Benchmark Report: MR2013.  Des Plaines, IL; IMV Medical Information Division, Inc.; 2013:7.
Falowski S, Safriel Y, Ryan M, Hargens L. The need for magnetic resonance (MR) imaging in the United States (US) deep brain stimulation (DBS) population. Presented at: 18th Annual North American
2Neuromodulation Society Conference; December 11-14, 2014; Las Vegas, NV. 

Related Articles Read More >

Carnegie Mellon University EEG-based BCI to control robotic hand
Non-invasive BCI enables robotic hand dexterity
How this device broke through the blood-brain barrier
A photo of the miniature Auxilium Biotechnologies implants made on the International Space Station.
Implants 3D-printed in space could enable nerve regeneration
An illustration showing the Artedrone Sasha thrombectomy catheter approaching a blood clot.
This microrobot system is designed to float inside a stroke patient for autonomous thrombectomy
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe